A novel mutation in the kinase domain of KIT in an Indian family with a mild piebaldism phenotype

Journal of Dermatological Science

Volumn 59, Issue 3, 2010, Pages 206-209

  Chong, Kai Ling ^a   Common, John E A ^b   Lane, E Birgitte ^b   Goh, Boon Kee ^a  

^a NATIONAL SKIN CENTRE   (Singapore)

^b INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; METHOXSALEN; PHOSPHOTRANSFERASE; STEM CELL FACTOR RECEPTOR;

CASE REPORT; CHILD; DEPIGMENTATION; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; FAMILY STUDY; FEMALE; HUMAN; INDIAN; LETTER; LEUKODERMA; MISSENSE MUTATION; PHENOTYPE; PHOTOCHEMOTHERAPY; PIEBALDISM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; SCHOOL CHILD; VITILIGO;

CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; FEMALE; HUMANS; MALE; MUTATION, MISSENSE; PIEBALDISM; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 77956177987     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.06.009     Document Type: Letter

References (10)

1. Geissler E.N., Ryan M.A., Housman D.E. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 1988, 55:185-192.
2. Spritz R.A., Giebel L.B., Holmes S.A. Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. Am J Hum Genet 1992, 50:261-269.
3. Giebel L.B., Spritz R.A. Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism. Proc Natl Acad Sci U S A 1991, 88:8696-8699.
4. Roskoski R. Structure and regulation of Kit protein-tyrosine kinase-the stem cell factor receptor. Biochem Biophys Res Commun 2005, 338:1307-1315.
5. Syrris P., Heathcote K., Carrozzo R., Devriendt K., Elcioglu N., Garrett C., et al. Human piebaldism: six novel mutations of the protooncogene KIT. Hum Mutat 2002, Mutation in Brief #528 (online).
6. Murakami T., Hosomi N., Oiso N., Giovannucci-Uzielli M.L., Aquaron R., Mizoguchi M., et al. Analysis of KIT, SCF, and initial screening of SLUG in patients with piebaldism. J Invest Dermatol 2005, 124:670-672.
7. Mol C.D., Lim K.B., Sridhar V., Zou H., Chien E.Y.T., Sang B.-C., et al. Structure of a c-kit product complex reveals the basis for kinase transactivation. J Biol Chem 2003, 278:31461-31464.
8. Murakami T., Fukai K., Oiso N., Hosomi N., Kato A., Garganta C., et al. New KIT mutations in patients with piebaldism. J Dermatol Sci 2004, 35:29-33.
9. Spritz R.A. Molecular basis of human piebaldism. J Invest Dermatol 1994, 103:137S-140S.
10. Sanchez-Martin M., Perez-Losada J., Rodriguez-Garcia A., et al. Deletion of the SLUG (SNAI2) gene results in human piebaldism. Am J Med Genet 2003, 122A:125-132.